These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 19641297

  • 1. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F, Federico G, Harrell JC, Saggese G.
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [Abstract] [Full Text] [Related]

  • 2. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 3. Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty.
    Massart F, Harrell JC, Federico G, Saggese G.
    J Adolesc Health; 2007 Mar; 40(3):252-7. PubMed ID: 17321426
    [Abstract] [Full Text] [Related]

  • 4. Prolactin secretion before, during, and after chronic gonadotropin-releasing hormone agonist treatments in children.
    Massart F, Parrino R, Placidi G, Massai G, Federico G, Saggese G.
    Fertil Steril; 2005 Sep; 84(3):719-24. PubMed ID: 16169408
    [Abstract] [Full Text] [Related]

  • 5. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK, Fan X, Tang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [Abstract] [Full Text] [Related]

  • 7. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ, Gillis D, Strich D, Chertin B, Farkas A, Lindenberg T, Gelber H, Spitz IM.
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 9. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 10. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone.
    Vottero A, Pedori S, Verna M, Pagano B, Cappa M, Loche S, Bernasconi S, Ghizzoni L.
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1284-7. PubMed ID: 16449342
    [Abstract] [Full Text] [Related]

  • 11. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 12. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R, Soros A, Jakubowicz S.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [Abstract] [Full Text] [Related]

  • 13. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F, Hofman PL, Jefferies C, Gunn AJ, Cutfield WS.
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [Abstract] [Full Text] [Related]

  • 14. Can bone age determination provide criteria for growth hormone treatment in adopted girls with early puberty?
    Proos LA, Lönnerholm T, Jonsson B, Tuvemo T.
    Ups J Med Sci; 2006 May; 111(1):117-29. PubMed ID: 16553251
    [Abstract] [Full Text] [Related]

  • 15. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [Abstract] [Full Text] [Related]

  • 16. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 17. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D, Oostdijk W, Waelkens JJ, Drop SL.
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
    [Abstract] [Full Text] [Related]

  • 18. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
    Su PH, Wang SL, Lin CY, Chen JY, Changlai CP, Jian SH, Chen SJ.
    Acta Paediatr Taiwan; 2005 Aug; 46(5):278-83. PubMed ID: 16640001
    [Abstract] [Full Text] [Related]

  • 19. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 20. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B, Julius JR, Blethen SL.
    Pediatrics; 1999 Oct 24; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.